how long to see results on retatrutide A Clinician's Guide Dosing Retatrutide Results: 28.3% Weight Loss

They raise and lower the risk for different reasons, at different times STUDY: Xie Y et al, BMJ Medicine 2026 STUDY TYPE: Cohort study (target trial emulation) FUNDING: US Department of Veterans Affairs Background Pancreatitis is a rare side effect of GLP-1 receptor agonists

GLP-1 medications work through a fundamentally different mechanismone that reduces appetite at the brain level rather than adding metabolic stress

These tablets offer a needle-free alternative that is already FDA-approved and in use

Cardiovascular benefits : Some studies indicate that GLP-1 receptor agonists may reduce the risk of cardiovascular events in patients with diabetes